Product Information
DABIGATRAN ETEXILATE 150 MG CP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.8226 per EA under NDC 62332063660. Its NADAC has been published 106 times since Aug 14, 2024.
FDA first approved this application on Jun 14, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332063660
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA215233FDA Approved
6/14/2024
TE Code
AB
On Market Since
6/14/2024
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 150 MG CP has been published 106 times since Aug 14, 2024, and over the history we have for it it has declined 54.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8226 per EA |
|---|---|
| All-time high | $2.4609 (Sep 11, 2024) |
| All-time low | $0.8226 (Aug 19, 2026) |
| 52-week high | $1.2631 |
| 52-week low | $0.8226 |
| Median price | $1.2898 |
| Average price | $1.3823 |
| Largest weekly change | +36.7% (Aug 21, 2024) |
| Weeks tracked | 106 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 150 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 150 MG CP, manufactured by Alembic Pharmaceuticals Inc., is $0.8226 per EA (NDC 62332063660), effective Aug 19, 2026.
How has the price of DABIGATRAN ETEXILATE 150 MG CP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 150 MG CP has declined 54.3%. It has been tracked across 106 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 150 MG CP?
Since Aug 14, 2024, the NADAC for DABIGATRAN ETEXILATE 150 MG CP has ranged from a low of $0.8226 (Aug 19, 2026) to a high of $2.4609 (Sep 11, 2024), with a median of $1.2898 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 150 MG CP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DABIGATRAN ETEXILATE 150 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 150 MG CP?
DABIGATRAN ETEXILATE 150 MG CP (NDC 62332063660) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.